Within the Gills Irrigating‑Aspirating Cannula segmentation, application is the primary driver of revenue distribution. Surgical usage accounts for the largest share, estimated at roughly 45 % of total sales, because the devices enable precise fluid management during orthopedic, cardiovascular and general surgery procedures, where high‑volume irrigation and simultaneous aspiration are critical for hemostasis and tissue clearance. Dental applications represent about 30 % of the market; the cannula’s fine gauge and controlled suction are suited for periodontal therapy, endodontic surgery and implant placement, where minimizing fluid retention reduces infection risk. Ear‑Nose‑Throat (ENT) procedures contribute an estimated 15 % as the instruments facilitate microsurgical field maintenance in sinus, tonsil and laryngeal surgeries, where limited operative space demands compact, dual‑function devices. Ophthalmic interventions, though a niche, comprise roughly 10 % of the market, supporting cataract extraction and vitreoretinal surgery where delicate irrigation‑aspiration balances intra‑ocular pressure. Collectively, these application segments define the market’s size and growth trajectory, with each sub‑segment’s adoption rate reflecting procedural volume and specialty‑specific regulatory pathways.